Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/12/10 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/12/10 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 06/15/10 | Definitive proxy statements |
|
50 | ||
| 06/10/10 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
10 | ||
| 06/04/10 | Current report filing |
|
4 | ||
| 05/14/10 | Quarterly report pursuant to Section 13 or 15(d) |
|
33 | ||
| 05/07/10 | Current report filing |
|
5 | ||
| 04/26/10 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 04/22/10 | Certification by the NASDAQ Stock Exchange approving securities for listing |
|
1 | ||
| 04/22/10 | Prospectus filed pursuant to Rule 424(b)(5) |
|
68 |